microRNA miR-144 modulates oxidative stress tolerance and associates with anemia severity in sickle cell disease.
暂无分享,去创建一个
[1] E. Miska. Faculty Opinions recommendation of The miR-144/451 locus is required for erythroid homeostasis. , 2010 .
[2] Michel Sadelain,et al. A Genetic Strategy for Single and Combinatorial Analysis of miRNA Function in Mammalian Hematopoietic Stem Cells , 2009, Stem cells.
[3] H. Grosshans,et al. Active turnover modulates mature microRNA activity in Caenorhabditis elegans , 2009, Nature.
[4] T. Katoh,et al. Selective stabilization of mammalian microRNAs by 3' adenylation mediated by the cytoplasmic poly(A) polymerase GLD-2. , 2009, Genes & development.
[5] S. Biswal,et al. Nrf2-regulated glutathione recycling independent of biosynthesis is critical for cell survival during oxidative stress. , 2009, Free radical biology & medicine.
[6] Saijuan Chen,et al. Mir-144 selectively regulates embryonic alpha-hemoglobin synthesis during primitive erythropoiesis. , 2009, Blood.
[7] V. Ambros,et al. The evolution of our thinking about microRNAs , 2008, Nature Medicine.
[8] Xuemei Chen,et al. Degradation of microRNAs by a Family of Exoribonucleases in Arabidopsis , 2008, Science.
[9] Yulei N. Wang,et al. The Genomic Analysis of Erythrocyte microRNA Expression in Sickle Cell Diseases , 2008, PloS one.
[10] Xiaowu Gai,et al. A GATA-1-regulated microRNA locus essential for erythropoiesis , 2008, Proceedings of the National Academy of Sciences.
[11] Stijn van Dongen,et al. miRBase: tools for microRNA genomics , 2007, Nucleic Acids Res..
[12] M. Socolovsky. Molecular insights into stress erythropoiesis , 2007, Current opinion in hematology.
[13] Shyam Biswal,et al. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. , 2007, Annual review of pharmacology and toxicology.
[14] S. Bonovas,et al. Redox imbalance, macrocytosis, and RBC homeostasis. , 2006, Antioxidants & redox signaling.
[15] E. Lam. Faculty Opinions recommendation of Posttranscriptional induction of two Cu/Zn superoxide dismutase genes in Arabidopsis is mediated by downregulation of miR398 and important for oxidative stress tolerance. , 2006 .
[16] W. Filipowicz,et al. Relief of microRNA-Mediated Translational Repression in Human Cells Subjected to Stress , 2006, Cell.
[17] G. Longmore. A unique role for Stat5 in recovery from acute anemia. , 2006, The Journal of clinical investigation.
[18] E. Fibach,et al. Red blood cells, platelets and polymorphonuclear neutrophils of patients with sickle cell disease exhibit oxidative stress that can be ameliorated by antioxidants , 2006, British journal of haematology.
[19] Mark T Gladwin,et al. Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease. , 2005, Blood.
[20] Paola Sebastiani,et al. Genetic dissection and prognostic modeling of overt stroke in sickle cell anemia , 2005, Nature Genetics.
[21] Jiang Li,et al. Stabilization of Nrf2 by tBHQ confers protection against oxidative stress-induced cell death in human neural stem cells. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.
[22] C. Burge,et al. Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.
[23] Masayuki Yamamoto,et al. Nrf2-Keap1 defines a physiologically important stress response mechanism. , 2004, Trends in molecular medicine.
[24] Y. Kan,et al. Targeted disruption of Nrf2 causes regenerative immune-mediated hemolytic anemia. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[25] W. Klitz,et al. Gene interactions and stroke risk in children with sickle cell anemia. , 2004, Blood.
[26] C. Brugnara,et al. Pathophysiological-based approaches to treatment of sickle cell disease. , 2003, Annual review of medicine.
[27] S. Orkin,et al. Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression , 2003, Nature.
[28] Y. Kan,et al. Identification of the NF-E2-related Factor-2-dependent Genes Conferring Protection against Oxidative Stress in Primary Cortical Astrocytes Using Oligonucleotide Microarray Analysis* , 2003, The Journal of Biological Chemistry.
[29] W. Klitz,et al. Distinct HLA associations by stroke subtype in children with sickle cell anemia. , 2003, Blood.
[30] R. Tibshirani,et al. Diagnosis of multiple cancer types by shrunken centroids of gene expression , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[31] A. Calzolari,et al. Accentuated response to phenylhydrazine and erythropoietin in mice genetically impaired for their GATA-1 expression (GATA-1(low) mice). , 2001, Blood.
[32] S. Mahajan,et al. Glutathione protects chemokine-scavenging and antioxidative defense functions in human RBCs. , 2001, American journal of physiology. Cell physiology.
[33] J. Chan,et al. Impaired expression of glutathione synthetic enzyme genes in mice with targeted deletion of the Nrf2 basic-leucine zipper protein. , 2000, Biochimica et biophysica acta.
[34] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[35] Ken Itoh,et al. Transcription Factor Nrf2 Coordinately Regulates a Group of Oxidative Stress-inducible Genes in Macrophages* , 2000, The Journal of Biological Chemistry.
[36] Ash A. Alizadeh,et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.
[37] K. Itoh,et al. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. , 1997, Biochemical and biophysical research communications.
[38] V. Tatum,et al. Antioxidant status and susceptibility of sickle erythrocytes to oxidative and osmotic stress. , 1996, Free radical research.
[39] C. Pegelow,et al. Clinical events in the first decade in a cohort of infants with sickle cell disease. Cooperative Study of Sickle Cell Disease. , 1995, Blood.
[40] G. Rodgers,et al. Mortality in sickle cell disease. , 1994 .
[41] O. Castro,et al. The acute chest syndrome in sickle cell disease: incidence and risk factors. The Cooperative Study of Sickle Cell Disease. , 1994, Blood.
[42] O. Platt,et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. , 1994, The New England journal of medicine.
[43] B. Fanburg,et al. Regulation of cellular glutathione. , 1989, The American journal of physiology.
[44] J W Eaton,et al. Pathobiology of heme interaction with the erythrocyte membrane. , 1989, Seminars in hematology.
[45] A. Prasad,et al. Altered amount and activity of superoxide dismutase in sickle cell anemia , 1988, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[46] R. Hebbel,et al. Abnormal redox status of membrane-protein thiols in sickle erythrocytes. , 1985, The Journal of clinical investigation.
[47] J. Eaton,et al. Spontaneous oxygen radical generation by sickle erythrocytes. , 1982, The Journal of clinical investigation.
[48] B. Lubin,et al. Abnormal vitamin E and glutathione peroxidase levels in sickle cell anemia: evidence for increased susceptibility to lipid peroxidation in vivo. , 1979, The Journal of laboratory and clinical medicine.
[49] B. Ames,et al. Erythrocyte glutamine depletion, altered redox environment, and pulmonary hypertension in sickle cell disease , 2009 .